247 related articles for article (PubMed ID: 18503988)
21. Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience.
Miano M; Cuzzubbo D; Terranova P; Giardino S; Lanino E; Morreale G; Castagnola E; Dini G; Faraci M
Bone Marrow Transplant; 2009 Mar; 43(5):423-7. PubMed ID: 18850021
[TBL] [Abstract][Full Text] [Related]
22. Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host disease.
Mayer J; Krejcí M; Doubek M; Pospísil Z; Brychtová Y; Tomíska M; Rácil Z
Bone Marrow Transplant; 2005 Apr; 35(7):699-705. PubMed ID: 15696180
[TBL] [Abstract][Full Text] [Related]
23. Infliximab for steroid-refractory acute GVHD: a case series.
Jacobsohn DA; Hallick J; Anders V; McMillan S; Morris L; Vogelsang GB
Am J Hematol; 2003 Oct; 74(2):119-24. PubMed ID: 14508798
[TBL] [Abstract][Full Text] [Related]
24. The changing face of graft-versus-host disease.
Schaffer JV
Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal photopheresis in graft-versus-host disease.
Carcagnì MR; De Aloe G; D'Ascenzo G; Rubegni P; Fimiani M
J Dtsch Dermatol Ges; 2008 Jun; 6(6):451-7. PubMed ID: 18177413
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody.
Hervé P; Racadot E; Wijdenes J; Flesch M; Tiberghien P; Bordigoni P; Holler E; Powles M; Bourdeau M; Wilmer E
Bone Marrow Transplant; 1991; 7 Suppl 2():149. PubMed ID: 1878688
[No Abstract] [Full Text] [Related]
27. Chronic graft-versus-host disease.
Cutler C; Antin JH
Curr Opin Oncol; 2006 Mar; 18(2):126-31. PubMed ID: 16462180
[TBL] [Abstract][Full Text] [Related]
28. Recent compounds for immunosuppression and experimental therapies for acute graft-versus-host disease.
Michael M; Shimoni A; Nagler A
Isr Med Assoc J; 2013 Jan; 15(1):44-50. PubMed ID: 23484241
[TBL] [Abstract][Full Text] [Related]
29. Daclizumab for children with corticosteroid refractory graft-versus-host disease.
Teachey DT; Bickert B; Bunin N
Bone Marrow Transplant; 2006 Jan; 37(1):95-9. PubMed ID: 16247417
[TBL] [Abstract][Full Text] [Related]
30. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
[TBL] [Abstract][Full Text] [Related]
31. Infliximab for GVHD therapy in children.
Sleight BS; Chan KW; Braun TM; Serrano A; Gilman AL
Bone Marrow Transplant; 2007 Sep; 40(5):473-80. PubMed ID: 17618323
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].
Martínez C
Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():69-71. PubMed ID: 21381292
[TBL] [Abstract][Full Text] [Related]
33. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
[TBL] [Abstract][Full Text] [Related]
34. B-cell involvement in chronic graft-versus-host disease.
Kapur R; Ebeling S; Hagenbeek A
Haematologica; 2008 Nov; 93(11):1702-11. PubMed ID: 18728020
[TBL] [Abstract][Full Text] [Related]
35. Impact of graft-versus-host disease on survival.
Pasquini MC
Best Pract Res Clin Haematol; 2008 Jun; 21(2):193-204. PubMed ID: 18503986
[TBL] [Abstract][Full Text] [Related]
36. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
Elad S; Levitt M; M Y S
Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
[TBL] [Abstract][Full Text] [Related]
37. Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.
Ratanatharathorn V; Pavletic S; Uberti JP
Cancer Treat Rev; 2009 Dec; 35(8):653-61. PubMed ID: 19682801
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide.
Mayer J; Krejci M; Pospisil Z; Doubek M; Janikova A; Zackova D; Racil Z; Smardova L; Navratil M; Kamelander J
Exp Hematol; 2009 Jun; 37(6):767-73. PubMed ID: 19463776
[TBL] [Abstract][Full Text] [Related]
39. The use of monoclonal antibodies for the treatment of graft-versus-host disease following allogeneic stem cell transplantation.
Busca A
Expert Opin Biol Ther; 2011 Jun; 11(6):687-97. PubMed ID: 21391897
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of corticosteroid refractory acute GVHD treated with an Inolimomab-based algorithm: a single center experience.
Girerd S; Renaud M; Guilhot J; Giraud C; Larchee R; Jollet I; Guilhot F
Bone Marrow Transplant; 2013 Sep; 48(9):1243-8. PubMed ID: 23503532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]